Potential conflict of interest: Dr. Heinen, Dr. Berweck, Dr. Borggraefe and Dr. Schroeder report having been paid lecture fees by Allergan, Inc., Merz Pharma, and Ipsen, Ltd., the manufacturers of the available Botulinum toxin preparations Botox®, Xeomin® and Dysport®, respectively. Dr. Heinen reports having received grant support from Allergan, Inc. and Merz Pharma in form of unrestricted educational grants. Dr. Heinen reports having received consulting fees from Allergan, Inc., Merz Pharma, and Ipsen, Ltd.
Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers†
Version of Record online: 1 JUN 2009
Copyright © 2009 Movement Disorder Society
Volume 24, Issue 10, pages 1494–1503, 30 July 2009
How to Cite
Schroeder, A. S., Ertl-Wagner, B., Britsch, S., Schröder, J. M., Nikolin, S., Weis, J., Müller-Felber, W., Koerte, I., Stehr, M., Berweck, S., Borggraefe, I. and Heinen, F. (2009), Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Mov. Disord., 24: 1494–1503. doi: 10.1002/mds.22661
- Issue online: 24 JUL 2009
- Version of Record online: 1 JUN 2009
- Manuscript Accepted: 20 APR 2009
- Manuscript Revised: 30 MAR 2009
- Manuscript Received: 1 DEC 2008
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.